Theratechnologies Newsroom

Sector Update: Health Care Stocks Softer in Late Afternoon Trading

MT NewswiresDec 18 15:53 ET

Sector Update: Health Care

MT NewswiresDec 18 15:21 ET

Theratechnologies Has Submitted A Prior Approval Supplement To The U.S. FDA Describing The Changes Made To The Manufacturing Environment Of The Facility Where EGRIFTA SV Is Produced

BenzingaDec 18 13:33 ET

Theratechnologies Announces Filing of FDA Prior Approval Supplement for EGRIFTA SV Manufacturing Environment

GlobeNewswireDec 18 13:30 ET

Theratechnologies Brief: Says Received March 2025 PDUFA Goal Date For Updated Tesamorelin F8 Formulation SBLA

MT NewswiresDec 10 15:15 ET

Theratechnologies Receives March 2025 PDUFA Goal Date for Updated Tesamorelin F8 Formulation SBLA

GlobeNewswireDec 10 15:15 ET

Theratechnologies Gets Medical Review Committee Approval for Higher Doses of TH1902 at Phase 1b Trial

MT NewswiresDec 9 08:55 ET

Theratechnologies Announces Preliminary Tolerability, Efficiacy Data for TH1902

TipRanksDec 9 08:47 ET

Theratechnologies Shows Promise in Ovarian Cancer Trial

TipRanksDec 9 08:14 ET

Theratechnologies Brief: Announcing Preliminary Tolerability and Efficacy Data From Phase 1b, Dose-Ranging Trial of Sudocetaxel Zendusortide in Patients With Advanced Ovarian Cancer

MT NewswiresDec 9 07:32 ET

Theratechnologies Announces Preliminary Tolerability and Efficacy Data From Phase 1b, Dose-Ranging Trial of Sudocetaxel Zendusortide in Patients With Advanced Ovarian Cancer

GlobeNewswireDec 9 07:30 ET

Ionis Grants Theratechnologies License To Commercialize Olezarsen And Donidalorsen For Use In Canada

RTTNewsDec 4 08:10 ET

Theratechnologies Expands Portfolio With Ionis Deal

TipRanksDec 4 08:09 ET

Theratechnologies to Commercialize Two RNA-targeted Medicines in Canada

MT NewswiresDec 4 08:08 ET

Theratechnologies Brief: Announcing Exclusive Licensing Agreement With Ionis to Commercialize Olezarsen and Donidalorsen in Canada

MT NewswiresDec 4 07:38 ET

Express News | Theratechnologies Resumes Production Of EGRIFTA SV Following Shutdown Of Facility To Address FDA Inspection

BenzingaDec 3 16:32 ET

Theratechnologies Announces Resumed Production of EGRIFTA SV

GlobeNewswireDec 3 16:30 ET

Theratechnologies Brief: Says "Favourable" Interest Rates and Amortization Schedules to Free up Near $19 Million in Cash in 2025 "To Support Business Development Strategy"

MT NewswiresDec 2 07:32 ET

Theratechnologies Brief: Secures up to $75 Million in New Credit Facilities With TD Bank and Investissement Quebec

MT NewswiresDec 2 07:31 ET

Theratechnologies Secures up to $75 Million in New Credit Facilities With TD Bank and Investissement Québec

GlobeNewswireDec 2 07:30 ET